11.06.2014 • News

Dieter Weinand Named to Head Bayer HealthCare Pharmaceuticals

Effective August 1, 2014, Dieter Weinand will become president of Bayer HealthCare Pharmaceuticals and at the same time join the Executive Committee of Bayer HealthCare. He replaces Andreas Fibig, who will leave Bayer on September 1, 2014, to become CEO of International Flavours and Fragrances.

The 53-year-old native of Boppard, Germany is currently president global commercialization & Portfolio management at Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey, USA. He has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry, including stints at Pfizer and Bristol-Myers Squibb.

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Aenova Holding GmbH

Aseptic processing by design: The flexible and efficient use of RABS and Isolators

most read

News • Strategy

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ineos CEO Ineos calls on European politicians to save the chemical industry.

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring

Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.

News • Bioprocessing

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

News • Chemistry

Dow to Shut Down Three Upstream European Assets

Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

News • Chemistry

Orion Announced Plans to Shut Down Carbon Black Plants

Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.